The Predictive Value of Thromboelastogram in the Evaluation of Patients with Suspected Acute Venous Thromboembolism.


Journal

Acta haematologica
ISSN: 1421-9662
Titre abrégé: Acta Haematol
Pays: Switzerland
ID NLM: 0141053

Informations de publication

Date de publication:
2020
Historique:
received: 16 06 2019
accepted: 24 07 2019
pubmed: 12 9 2019
medline: 25 8 2020
entrez: 12 9 2019
Statut: ppublish

Résumé

The objective of this prospective study was to examine whether thromboelastogram (TEG) can predict the presence of venous thromboembolism (VTE) in patients who arrive at the emergency room with signs/symptoms that raise the suspicion of acute VTE. Every patient was tested for D-dimer and all TEG parameters, including: reaction time, clot time formation, alpha-angle, maximal amplitude, clot viscoelasticity, coagulation index, and clot lysis at 30 min. For categorical variables, χ2 or the Fisher exact test were used, and for continuous variables the t test or other non-parametric tests were used. During 2016, a total of 109 patients were enrolled with a median age of 55.7 (21-89) years. Eighteen patients were diagnosed with VTE. Analyzing the different TEG parameters, both as continuous and categorical variables, did not reveal a statistically significant difference between VTE-positive and VTE-negative patients. Combining different TEG parameters or dividing the cohort according to gender, clinical suspicion of VTE (Well's criteria), or different levels of D-dimer did not change the results of the analysis. The current study could not demonstrate a significant value of any TEG parameter as a predictor of VTE among patients who came to the emergency room with signs/symptoms that raise the suspicion of VTE.

Identifiants

pubmed: 31509839
pii: 000502348
doi: 10.1159/000502348
doi:

Substances chimiques

Fibrin Fibrinogen Degradation Products 0
fibrin fragment D 0

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

272-278

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Tareq Abu Assab (T)

Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel.

David Raveh-Brawer (D)

Infectious Diseases Unit, Shaare Zedek Medical Center, Jerusalem, Israel.

Julia Abramowitz (J)

Hematology Laboratory, Shaare Zedek Medical Center, Jerusalem, Israel.

Mira Naamad (M)

Blood Bank, Shaare Zedek Medical Center, Jerusalem, Israel.

Chezi Ganzel (C)

Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel, ganzelc@szmc.org.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH